Charleston, SC, United States of America

Gautam Ghatnekar

USPTO Granted Patents = 16 

 

 

Average Co-Inventor Count = 1.7

ph-index = 6

Forward Citations = 111(Granted Patents)


Location History:

  • Charleston, NC (US) (2014)
  • Charleston, SC (US) (2010 - 2020)

Company Filing History:


Years Active: 2010-2020

Loading Chart...
Loading Chart...
Loading Chart...
16 patents (USPTO):

Title: The Innovations of Gautam Ghatnekar: A Pioneer in Therapeutic Peptides

Introduction: Gautam Ghatnekar, located in Charleston, SC, has established himself as an innovative inventor in the field of therapeutic peptides. With an impressive portfolio of 16 patents, Ghatnekar is renowned for his groundbreaking contributions to medicine, particularly in the treatment of chronic wounds and macular degeneration.

Latest Patents: Among Ghatnekar's latest patents is a formulation and method for using alpha connexin C-terminal (ACT) peptides. This invention focuses on a topical gel drug product preparation that contains an isolated polypeptide with a carboxy-terminal amino acid sequence of an alpha connexin. This innovative formulation also incorporates peptide stabilizers, excipients, and buffering agents. The resulting gel is not only stable and elegant but is designed for long-term storage, making it suitable for aesthetic and therapeutic applications. Furthermore, it aids in preventing scarring and accelerates wound healing. Another notable patent from Ghatnekar involves the application of ACT peptides in treating or preventing macular degeneration, preserving organs for transplantation, and preventing cellular injury in organs.

Career Highlights: Ghatnekar has had a distinguished career, contributing significantly to the development of new therapeutic solutions. His work at the MUSC Foundation for Research Development and Firstring Research, Inc. has been pivotal in advancing the understanding and applications of therapeutics in medicine.

Collaborations: Throughout his career, Ghatnekar has collaborated with notable colleagues, including Robert G. Gourdie and Jane Jourdan. These professional partnerships have further enriched his research and invention processes, allowing for the exploration of innovative solutions in the medical field.

Conclusion: Gautam Ghatnekar's contributions to science and medicine through his extensive patent portfolio are commendable. His work in developing formulations and methods using ACT peptides has the potential to revolutionize treatments for chronic wounds and age-related conditions. His collaborative approach and innovative mindset will undoubtedly continue to influence the field for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…